Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00224172 · ClinicalTrials.gov registry record
Ambulatory Care Characteristics as Predictors of Mortality and Re-Admission
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 302
- Enrollment target
NCT00224172: Completed study, sponsored by Weill Medical College of Cornell University.
NCT00224172 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 302 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00224172 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 302 participants
- Enrollment target
Study Summary
The aim of this study is to construct a prognostic model to identify risks of poor outcomes at one year following hospital discharge of patients treated in an ambulatory cate setting. The study will incorporate pre-hospitalization characteristics, hospitalization events, comorbidity burden, psychosocial measures and post-hospitalization care characteristics to predict re-hospitalization and mortality at one year.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2001-01 |
| Est. Completion | 2001-12 |
What the finished NCT00224172 record still lists
NCT00224172 is an observational study that tracks outcomes without assigning an intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00224172 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00224172 about?
NCT00224172 is a clinical study titled "Ambulatory Care Characteristics as Predictors of Mortality and Re-Admission". The aim of this study is to construct a prognostic model to identify risks of poor outcomes at one year following hospital discharge of patients treated in an ambulatory cate setting. The study will incorporate pre-hospitalization characteristics, hospitalization events, comorbidity burden, psychoso...
What is the current status of trial NCT00224172?
This trial is currently completed. The enrollment target is 302 participants. The study started on 2001-01. Estimated completion is 2001-12.
Who is sponsoring clinical trial NCT00224172?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia